Skip to content
Learn More

Posts by Amy Ripston

November 8, 2022
The Rising Complexity of Ancillary Management

A few years ago, we asked a group of clinical research sites if there were any challenges in receiving, tracking, or storing ancillaries. The overwhelming consensus was that...

Learn More
November 8, 2022
Real-time drug tracking is set to become an industry standard

Be sure to listen to the January 2022 episode of the Trial Trends podcast, "3 Trends That Will Shape 2022" for more insights for 2022 and beyond.

Learn More
November 8, 2022
Master Protocol Studies – A Map to an Unknown Destination

Learn More

Filter by Topic

July 8, 2022
The Rising Complexity of Ancillary Management
Read More
September 15, 2021
A Metastatic Breast Cancer (MBC) Patient’s Journey to ‘No Active Disease’
Read More
September 1, 2021
A Rare Disease Patient Sheds Light on Journey for Treatment
Read More
September 30, 2020
Is Direct-to-Patient (DtP) the Tip of the Virtual Trial Iceberg?
Read More
May 29, 2020
5 Supply Chain Impacts Resulting from Master Protocol Amendments – And How to Prepare
Read More
May 15, 2020
3 Simple Steps to Manage Multiple Protocol Versions in a Single Study
Read More
May 7, 2020
Master Protocol Studies – A Map to an Unknown Destination
Read More
March 23, 2020
The Site Perspective: COVID-19 and the movement towards Direct-to-Patient trials
Read More
March 19, 2020
Is Now The Right Time To Switch To Direct-to-Patient (DtP) Trials?
Read More